Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,372 | 8,455 | 5,402 | 2,829 | 9,618 |
| Depreciation Amortization | 1,692 | 1,216 | 816 | 415 | 933 |
| Income taxes - deferred | -2,667 | -2,748 | -2,736 | -2,819 | 456 |
| Accounts receivable | -1,263 | -1,299 | -1,732 | -1,239 | 391 |
| Other Working Capital | 5,822 | 7,751 | 5,873 | 6,924 | -506 |
| Other Operating Activity | 1,397 | 1,399 | 1,799 | 1,273 | -285 |
| Operating Cash Flow | $16,352 | $14,775 | $9,422 | $7,383 | $10,607 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,693 | -15,021 | -7,231 | -2,936 | -20,110 |
| Investing Cash Flow | $-16,693 | $-15,021 | $-7,231 | $-2,936 | $-20,110 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 711 | 529 | 177 | 177 | 2,824 |
| Common Stock Repurchased | -1,049 | -898 | -693 | -399 | -1,803 |
| Other Financing Activity | 303 | 224 | 151 | 151 | 3,808 |
| Financing Cash Flow | $-34 | $-145 | $-364 | $-70 | $4,830 |
| Beginning Cash Position | 5,138 | 5,138 | 5,138 | 5,138 | 9,811 |
| End Cash Position | 4,763 | 4,748 | 6,964 | 9,515 | 5,138 |
| Net Cash Flow | $-375 | $-390 | $1,827 | $4,377 | $-4,673 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,352 | 14,775 | 9,422 | 7,383 | 10,607 |
| Free Cash Flow | 16,352 | 14,775 | 9,422 | 7,383 | 10,607 |